Andere Sprachen Adicet Bio, Inc.

Aktien

A2QESQ

US0070021086

ACET

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 09.05.2024			% 5 Tage	% 1. Jan.
1,63 ^USD	-1,21 %		+15,60 %	-13,76 %

22.04.	Adicet Bio, Inc. hebt in einer mündlichen Präsentation auf der 27. Jahrestagung der ASGCT präklinische Daten hervor, die die IND-Reife von ADI-270 unterstützen	CI
19.03.	Adicet Bio, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference	07.05.
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	30.04.
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy 27th Annual Meeting	23.04.
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting	22.04.
Adicet Bio, Inc. Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the ASGCT 27th Annual Meeting	22.04.
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference	08.04.
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	28.03.
North American Morning Briefing : Markets Steady -2-	26.03.
Adicet Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19.03.
Adicet Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	19.03.
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress	19.03.
Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference	11.03.
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	01.03.
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	05.02.
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	31.01.
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares	26.01.
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares	25.01.
Sector Update: Health Care Stocks Mixed Premarket Tuesday	23.01.
Adicet Bio Prices $85.2 Million Share Offering	23.01.
Adicet Bio, Inc. Announces Pricing of Public Offering	23.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Adicet Bio, Inc.

Aktien

A2QESQ

US0070021086

ACET

Andere Sprachen

Filter